INTRODUCTION {#sec1-1}
============

Pediatric diarrhea is frequently lethal since this illness causes severe dehydration\[[@ref1]\]. There are multiple causes of the disease, including bacterial, parasitic and viral infections\[[@ref2]-[@ref4]\]. Viruses, specifically of the rotavirus group A, are the predominant factors of viral gastroenteritis in children aged \<5 years worldwide\[[@ref5]\]. Rotaviruses have high frequency rates of morbidity and mortality in developed and developing countries, respectively\[[@ref6]\]. These viruses are transmitted via the fecal-oral route, which can happen directly from person to person and through contaminated drinking water\[[@ref7]\]. It has been estimated that about 125 million cases of diarrhea and more than 453,000 deaths occur annually in the world due to gastroenteritis caused by rotaviruses\[[@ref8]-[@ref10]\].

Rotaviruses are non-enveloped, double-stranded RNA viruses belonging to the Reoviridae family. The genome comprises 11 segments that encode six structural proteins (*VP1-VP4*, *VP6*, and *VP7*) and six non-structural proteins (*NSP1-NSP5*/*NSP6*). The serologic cross-reactivity of the middle layer protein, *VP6*, has firmly identified seven serogroups (A-G); however, based on *VP6* genetic diversity, there are likely at least eight serogroups (A-H)\[[@ref11]-[@ref13]\]. The majority of human rotavirus infections belong to group A, though some strains of rotaviruses in groups B and C can also cause diarrhea in humans.

Rotaviruses are classified based on their serological characteristics or the genetic diversity of two outer capsid proteins, *VP7* (glycosylated, G-type) and *VP4* (protease sensitive, P-type)\[[@ref14]\], since these protein targets for antibodies are important for broadening vaccine\[[@ref15]\]. So far, 27 different G- and 37 different P-genotypes have been identified, and approximately, 73 G/P genotypes of group A rotavirus have been reported to be responsible for acute diarrhea in humans\[[@ref16],[@ref17]\]. The common major rotavirus genotypes, i.e. G1-G4, G9, P\[8\], P\[4\], and P\[6\], have been found to act as the causative agents for gastroenteritis\[[@ref18],[@ref19]\]. Recently, the emergence of the novel G12 rotavirus has been detected in different parts of the world\[[@ref20]-[@ref26]\]. A high frequency of G12 associated with multiple *VP4* genotypes has been reported in India, Bangladesh, and Nepal\[[@ref27]-[@ref30]\]. Of all the possible combinations, six genotypes (G1P\[8\], G2P\[4\], G3P\[8\], G4P\[8\], G9P\[8\], and G12P\[8\]) have been observed in 80-90% of the isolated rotavirus infections\[[@ref31]-[@ref34]\].

Both surfaces *VP7* and *VP4* genotypes are able to induce neutralization antibodies and are targets for the vaccine development\[[@ref15]\]. Two live, attenuated oral vaccines, Rotarix (GlaxoSmithKline Biologicals, Rixensart, Belgium) and RotaTeq (Merck, Blue Bell, PA, USA) provide protection against severe gastroenteritis caused by the main rotavirus serotypes in circulation and contribute to a significant decrease in diarrhea cases in developed and also in developing countries\[[@ref33]\].

Based on data provided by 19 studies in Iran, the prevalence of rotavirus infection has been 36.5% (range 15.3%-67.6%). This pattern is similar to rotavirus infection prevalence in the Eastern Mediterranean region\[[@ref35]\]. However in Iran, there is little available information on rotavirus genotype, and limited studies from Iran have reported data on rotavirus G-P combinations. Overall, in Iran, G1P\[8\], G2P\[4\], and G4P\[8\] accounted for over 60% of all rotavirus G-P combinations analyzed\[[@ref35]\]. Jalilvand *et al*.\[[@ref36]\] evaluated the diversity of *VP7* genes of G1 rotaviruses isolated in Iran. Genetic variations in the *VP7* gene of rotavirus G1 genotype isolates from Iran indicated that rotavirus strains clustered with G1 lineages IA, IC, and IIC. Mapping the rotavirus genotypes distribution will help to determine the epidemiology of the virus strains, especially in different geographic locations. Also, the identification of a novel rotavirus strain may be achieved through a reassortment and interspecies transmission of rotavirus strains from animals to humans. The genotyping of rotavirus is critical to know whether the current vaccines cover the most common genotypes of a certain region\[[@ref37]\]. In this research, we aimed to determine the genotype distribution of rotaviruses in children with acute gastroenteritis, admitted to Aboozar Children's Hospital of Ahvaz, Iran.

MATERIALS AND METHODS {#sec1-2}
=====================

Patients and sample collection {#sec2-1}
------------------------------

For the purpose of a six-month surveillance, after diagnosis of gastroenteritis by a pediatrician, a total of 100 stool samples were obtained from children under five years old with acute diarrhea (diarrhea, vomiting, and abdominal pain less than two weeks) who referred to the Aboozar Children's Hospital of Ahvaz city (Khuzestan, Iran) during October 2015 to March 2016. Demographic data and clinical signs are presented in [Table 1](#T1){ref-type="table"}. The children with chronic diarrhea were excluded from the study. Stool specimens were collected and transferred to the clinical laboratory for bacterial culture. All fecal samples were negative for the presence of white blood cells, parasite, and amoeba, and bacterial culture for salmonella, shigella, and other pathogens were transported on ice to the Virology Department and stored at -70ºC for molecular investigations.

###### 

Demographic data and clinical features

  Characteristics   Rotavirus infection   *p* value   
  ----------------- --------------------- ----------- --------------------------------------
  Sex                                                 
   Male             59.4                  53.1        0.52
   Female           40.6                  46.9        
  Age                                                 
   \>2 years        21.9                  25.0        0.85
   \<2 years        78.1                  75.0        
  Symptom                                             
   Vomiting         93.8                  60.3        0.00[\*](#t1f1){ref-type="table-fn"}
    Fever ≥38 °C    75.0                  52.9        0.01[\*](#t1f1){ref-type="table-fn"}

Statistically significant difference

Antigen detection {#sec2-2}
-----------------

All faecal samples were screened for the presence of rotavirus antigen using a commercial latex agglutination kit (Omega Diagnostics Ltd., Omega House, Hillfoots Business Village, Alva FK12 5DQ, Scotland, United Kingdom) according to the manufacturer's guidelines. Rotavirus antigen-positive fecal samples were stored at -70 °C until use.

Nucleic acid extraction and cDNA preparation {#sec2-3}
--------------------------------------------

For those rotavirus antigen-positive samples identified by the latex agglutination test, a faecal suspension of 10% (w/v) was prepared using phosphate-buffered saline, vortexed and centrifuged at 3000 ×g for 15 min. A 200-µl supernatant was collected and used for total RNA extraction using Trizol (Cinagen kit, Iran) according to the manufacturer's protocol. Following the RNA extraction, 6-µl extracted dsRNA was converted to cDNA with a commercial cDNA Synthesis Kit (Thermo Fisher Scientific, USA). Before the reverse transcription reaction, the RNA samples were incubated at 97 °C for 5 min with *VP6* forward primer, *Vp7* G con reverse primer, and *VP4* con3 forward primer (20 pmol each, 1 µM final concentration). The initial reverse transcription reaction was carried out at 42 °C for 60 min, followed by an inactivation step of 70 °C for 5 min.

RT-PCR for VP6 {#sec2-4}
--------------

Following cDNA synthesis, RT-PCR was performed using specific primer for *VP6* to confirm rotavirus group A ([Table 2](#T2){ref-type="table"}). The PCR reaction mixture was composed of the 1× PCR buffer (75 mM Tris/HCl \[pH 8.8\], 1 mM MgCl~2~, 200 µM dNTP mix (Cinagen, Iran), 1 U Taq DNA polymerase (Cinagen, Iran), 1 µl of each primer (10 pmol; Bioneer Company, South Korea), and 2.5 µl of the template. The PCR was performed on peqSTAR 2× (PEQLAB Biotechnologie GmbH, Erlangen, Germany) for 35 cycles. Cycling conditions were as follows: 94 °C for 5 min; 35 cycles at 94 °C for 30 s, 50 °C for 30 s, 72 °C for 1 min, and a final elongation at 72 °C for 10 min. The expected PCR product was 382 bp. The PCR product was subjected to electrophoresis on a 2% agarose gel, stained with a DNA safe stain and observed under ultraviolet light.

###### 

Primers corresponded to VP6, VP7, and VP4 genes for rotavirus genotyping

  Primer              Type     Sequence (5′--3′)                Position    PCR product (bp)
  ------------------- -------- -------------------------------- ----------- ------------------
  VP6-Forward                  GACGGV(c)GCR(b)ACTACATGGT        747-766     382\[[@ref39]\]
  VP6-Reverse                  GTCCAATTCATN(d)CCTGGTG           1126-1106   
  G-typing (VP7)                                                            
  Gcon Reverse                 GGTCACATCATACAATTCT              1062-1044   
    aBT1              G1       CAAGTACTCAAATCAATGATGG           314-335     749
    aCT2              G2       CAATGATATTAACACATTTTCTGTG        411-435     652
    Aust              G3       ACGAACTCAACACGAGARG              250-269     813
    aDT4              G4       CGTTTCTGGTGAGGAGTTG              480-498     584
    aAT8              G8       GTCACACCATTTGTAAATTCG            178-198     885
    mG9               G9       CTTGATGTGACTAYAAATAC             757-776     305
  P-typing (VP4)                                                            
    con3 Forward               TGGCTTCGCTCATTTATAGACA           11-32       
    2T-1              P\[4\]   CTATTGTTAGAGGTTAGAGTC            474-494     484
    3T-1              P\[6\]   TGTTGATTAGTTGGATTCAA             259-278     260
    1T-1              P\[8\]   TCTACTTGGATAACGTGC               339-356     346
    4T-1              P\[9\]   TGAGACATGCAATTGGAC               385-402     392
  Universal primer                                                          
    VP7con1 Forward            ATGTATGGTATTGAATATACCAC          51-71       1014
    VP7con2 Reverse            GGT CAC ATC ATA CAA TTC TAA TC   1062-1040   
    VP4con1 Forward            TGGCTTCGCTCATTTATAGACA           2-23        877
    VP4con1 Reverse            ATY TCH GAC CAY TTA TAH CC       878-859     

\[c = (N = A, T, C or G), b = (R = A or G), d = (Y = C or T)\]\[[@ref18]\]

Genotyping (G and P) of the strains {#sec2-5}
-----------------------------------

Genotyping of samples were conducted according to the WHO manual for rotavirus detection and characterization methods, with the minimal modification of genotyping protocols\[[@ref38]\]. A semi-multiplex PCR was employed to amplify the *VP7* and *VP4* genes. For the detection of *VP7* genotypes, following forward primers, aBT1 G1, aCT2 G2, G3-Aust, aDT4 G4, aAT8 G8, mG9 as an Asian Type, and End9 reverse primers for *VP7* were used to be genotyped by semi-multiplex PCR. For the identification of *VP4* genotypes, the appropriate forward and reverse primers were used [Table 2](#T2){ref-type="table"}).

Typically, the semi-multiplex PCR was performed in a 25-µl volume containing 1× PCR buffer (75 mM Tris/HCl \[pH 8.8\], 1 mM MgCl~2~, 200 µM dNTP mix) and the appropriate primer mixture (10 pm each and 1 U Taq polymerase). Also, 2.5-µl cDNA was utilized following the thermal-cycling conditions, as described here. The PCR products were electrophoresed on 2% agarose gel, and the G and P genotypes were determined by the sizes of the amplicons ([Table 2](#T2){ref-type="table"}). Specimens that did not react with either G- or P-type-specific primers were recorded as non-typeable, and cDNA was again synthesized with universal primers (*VP7* con 1F and *VP4* con 1F), and then semi-multiplex PCR was carried under the same condition.

Sequence analysis for non-typeable strains {#sec2-6}
------------------------------------------

A total of 16 PCR products of *VP7* and *VP4* non-typeable strains were sequenced (Bioneer, South Korea). The *VP7* and *VP4* sequences were compared with the sequences retrieved from the GenBank using the online nucleotide BLAST, National Center for Biotechnology Information (NCBI) (<http://www.ncbi.nlm.nih.gov/BLAST/>).

GenBank accession numbers {#sec2-7}
-------------------------

The nucleotide sequence data of gene segments of G12 strains were deposited in the GenBank database and given accession numbers.

Phylogenetic analysis {#sec2-8}
---------------------

To clarify the relationship between the rotavirus isolates, phylogenetic analysis was performed based on *VP7* region. Rotavirus nucleotide sequences were aligned by MUSCLE (Mega 6.0 software). Genetic distances were calculated by the Kimura's two-parameter substitutions model, and phylogenetic tree was then constructed by the Maximum Likelihood method. The bootstrap probability at a branching point was calculated with 500 pseudo-replicate datasets.

Ethical consideration {#sec2-9}
---------------------

This project (Registration NO.OG-94134) was approved by the ethics committee of Ahvaz Jundishapur University of Medical Sciences (Ahvaz, Iran). All experiments were performed in compliance with relevant laws and institutional guidelines and in accordance with the ethical standards of the Declaration of Helsinki. Stool samples were collected only from those patients who were interested to donate their stool voluntarily. Information pertaining to each patient under the study was kept confidential.

Statistical analysis {#sec2-10}
--------------------

Statistical analysis was performed using the software SPSS, version 19.0. Differences between the groups according to the variables were analyzed using the chi-square (χ^2^) test. *p* values ≤0.05 were considered statistically significant.

RESULTS {#sec1-3}
=======

One hundred faecal samples were collected from 55 (55%) males and 45 (45%) females with acute gastroenteritis during October 2015 to March 2016. The patients' ages were between 2 and 60 months, with a mean age of 13.40 ± 11.01 months. The rotavirus was detected in 38% (38/100) of patient samples. Six out of 38 (15.78%) rotavirus antigen-positive samples turned out to be negative in the diagnoses of rotavirus by the RT-PCR method. Most rotavirus (10 of 32) detections were observed in children between 6 and 8 months of age. Our analysis of the G and P genotypes of strains from all 32 rotavirus-infected children revealed: 5/32 (15.6%) G type strains and 11/32 (34.3%) P type strains were found non-typeable. Based on the nucleotide sequencing of 1014 bp *VP7* gene fragments and the high degree of identity of the sequences with the GenBank database, 2/5 non-typeable genotypes were identified as G1 and G2 genotypes, and 3/5 non-typeable strains were identified as G12 genotype. All the non-typeable strains for *VP4* were found to be P\[8\] by nucleotide sequencing of 877-bp *VP4* gene fragments. The rest of the strains were identified as G1-G4, G9, P\[4\], and P\[8\] genotypes. The predominant *VP7* genotyping (G type) was G9 (37.5%), followed by G2 (21.9%), G1 (12.5%), G12 (9.4%), G4 (9.4%), G2G9 (6.3%), and G3 (3.1%). As for *VP4* genotyping (P type), P\[8\], P\[4\], and P\[4\] P\[8\] accounted for 62.5%, 31.3%, and 3.1%, respectively. The distribution of human RVA G/P combinations is shown in [Figure 1](#F1){ref-type="fig"}. Combinations of G typing and P typing were classified as common (G2P\[4\], G1P\[8\], and G4P\[8\]) and uncommon. Common RVA typing was detected in 37.6%. The common and uncommon typing data are shown in [Table 3](#T3){ref-type="table"}. The predominantly common strains were G2P\[4\] (18.8%), followed by G1P\[8\] (9.4%) and G4P\[8\] (9.4%). Interestingly, the present research indicated a high prevalence (62.4%) of unusual G/P combinations. The predominantly uncommon genotype was G9P\[8\] (28.1%). Notably, a novel rotavirus strain with G12P\[8\] that had not been earlier reported in the south of Iran was detected for the first time. Furthermore, the low percentages of mixed infections of 6.3% G types and 3.1% P types were also observed. Only 1 (3.1%) non-typeable (P type) rotavirus strain was detected in this study. [Figure 2](#F2){ref-type="fig"} shows the nucleic acid identities of the Iranian and other isolates. The GenBank accession numbers for our nucleotide sequences of G12 strains were: KY412192, KY412193, and KY412194.

![Distribution of human species RVA G/P combinations in children with acute diarrhea](IBJ-22-107-g001){#F1}

###### 

Common and uncommon genotyping in infected patients

  Genotyping        N    \%
  ----------------- ---- ------
  Common                 
   G2P\[4\]         6    18.8
   G1P\[8\]         3    9.4
   G4P\[8\]         3    9.4
   Subtotal         12   37.6
  Uncommon               
   G9P\[8\]         9    28.1
   G12P\[8\]        3    9.4
   G2G9P\[4\]       2    6.3
   G2P\[8\]         1    3.1
   G3P\[8\]         1    3.1
   G9P\[4\]         1    3.1
   G1P\[4\]         1    3.1
   G9P\[4\]P\[8\]   1    3.1
   G9P\[untype\]    1    3.1
  Subtotal          20   62.4

N, number

![Phylogenetic tree for the G12 VP7 genes from human rotavirus strains available in the DNA databases. The phylogenetic tree was constructed by the Maximum Likelihood method, the genetic distances were computed according to the Kimura 2-parameter model, bootstrap values were obtained after 500 replicate trials, and the VP7 gene of the strain L26 was used as the outgroup.](IBJ-22-107-g002){#F2}

DISCUSSION {#sec1-4}
==========

In the present study, almost all known rotaviruses of the G and P types were detected in children with acute gastroenteritis in the Southwest of Iran. Additionally, the emergence of a new G12 type was reported in this study. Rotaviruses are the single most important causes of severe diarrhea in children below five years of age worldwide, accounting for 30% to 50% of the acute diarrheal disease\[[@ref40]\]. In the current study, rotavirus infection was detected in one-third of the patients with acute diarrhea (32%). We characterized the *VP7* and *VP4* gene segments and determined the most prevalent rotavirus genotype combinations. The rotavirus genotypes identified were highly diverse. Genotypic variations were further classified as common and uncommon, as described by Kobayashi *et al*.\[[@ref41]\]. We found genotype G9P\[8\], with the prevalence of 28.1%, to be the dominant genotype in the patients studied, while in our previous study, the predominant rotavirus was the G1 genotype, followed by G2\[[@ref42]\].

Non-typeable RVAs have been reported in nearly all epidemiologic studies around the world. The reason for the occurrence of non-typeable genotypes is not clear, but it could be due to point mutation at the primer-binding site of the rotavirus gene or to the newly emerging-rotavirus genotypes. A considerable amount of non-typeable genotypes has been reported in studies for G (20.2%; range 5%-41%) and P (17%; range 1.4%-28.2%) genotypes\[[@ref19]\]. The most prevalent genotypes, G1P\[8\], G2P\[4\], G3P\[8\], G4P\[8\], G9P\[8\], and G9P\[6\], have been reported in the USA\[[@ref43]\]. Similarly, G1P\[8\] has been reported to be the most frequent genotype in most European countries\[[@ref34]\]. Overall, G1P\[8\], G2P\[4\], G3P\[8\], and G4P\[8\] were the four most common predominant genotypes worldwide\[[@ref19]\]. The prevalence of each genotype was 52%, 11%, 3%, and 8%, respectively\[[@ref19],[@ref44]\]. These results differ from our study and other studies in some parts of the world. Soenarto *et al*. \[[@ref45]\] found G1P\[6\] to be the predominant genotype, but Putnam *et al*.\[[@ref46]\] identified G2P \[[@ref4]\] genotype as the dominant genotype, followed by G1P\[6\]. Studies in Romania and Denmark have demonstrated the G9P\[8\] genotype to be the predominant type, matching the findings of our study and studies from Turkey\[[@ref47]-[@ref49]\]. In Turkey, the most frequent GP combinations were G9P\[8\] (40.5%), followed by G1P\[8\] (21.6%), G2P\[8\] (9.3%), G2P\[4\] (6.5%), G3P\[8\] (3.5%), and G4P \[[@ref8]\] (3.4%). Although the current study was similar to the Turkey's study in the G9P8 increasing, there was a difference in the emersion of the G12P8 combination. Ahmed *et al*.\[[@ref50]\] in Iraq detected rotavirus in 40% of Iraqi children with acute gastroenteritis. The most prevalent genotype was G2 (40%), most often associated with P\[6\], followed by G1 (16%), which was mainly associated with P\[8\] and P\[UT\]. G3, G4, and G9 were detected at a lower prevalence (3%, 11%, 3%, respectively), mainly related to P\[6\]. Surprisingly, five G8P\[6\] and seven G12 RVA strains in combination with P\[6\] and P\[8\] were also detected for the first time in Iraq\[[@ref50]\]. In addition, in India, Mullick *et al*.\[[@ref51]\] have reported G1P\[8\], G9P\[8\], G2P\[4\], and G9P\[4\]\[[@ref51]\]. In Japan, Numazaki *et al*.\[[@ref52]\] have detected G1P\[8\], G3P\[8\], and G9P\[8\] as the most common genotypes. Kim *et al*.\[[@ref11]\], in the Republic of Korea, identified the most common genotypes as G1P\[8\], G2P\[4\], and G9P\[8\] in children with acute diarrhea. In Cameroon, Boula *et al*. \[[@ref53]\] reported that G9P\[8\], G1P\[8\], and G3P\[6\] genotypes were the most common genotypes detected in children with acute gastroenteritis. Interestingly, in our study, the emergence of the G12 was found in the G12P\[8\] combination, whereas the combination of G12P\[6\] has been detected in the most parts of the world\[[@ref54]\]. The G12 genotype was first detected in the Philippines in 1987\[[@ref55]\] and then in several other places\[[@ref56]\]. In Tehran, Farahtaj *et al*.\[[@ref57]\] reported G9P\[8\] (15.5%) and G12P\[8\](1.4%), but Shoja *et al*.\[[@ref35]\] identified G9P\[8\] (2.4%) and G12P \[[@ref8]\] (0.2%). In the present study, the phylogenetic analyses for *VP7* showed that the *VP7* sequences identified in the Iran/2016 isolates (accession NO. KY412192, KY412193, and KY412194) belong to the G12 cluster statistically supported by 96% bootstrap value ([Fig. 2](#F2){ref-type="fig"}). The similarity of identified nucleic acids among Iranian G12 isolates and Thailand G12 strains were clearly high (\~99%). Furthermore, to identify the geographical regions that were the source of the Iranian G12 strain, more samples must be collected from other parts of the country, and a phylogenetic tree needs to be drawn separately. Based on the result of BLASTX, there was 99% amino acid identity among the KY412192 and KY412193 Iranian G12 isolates with the ANJ45307.1 Italian strain. Additionally, the tree indicated that the KY412194 Iranian G12 isolate was 100% identical to ALQ11673.1 isolate from Thailand ([Fig. 2](#F2){ref-type="fig"}).

The phylogenetic analyses for *VP7* by Jalilvand *et al*.\[[@ref36]\] showed that nucleotide and amino acid sequences of G1 from Iran had the highest average (93.3% and 95.7%, respectively) of similarity compared with reference sequences of the G1 lineages I and II, However, it demonstrates an average nucleotide and amino acid similarity of 83-92.8% and 90-93.9%, respectively versus all other G1 lineages (III-XI).

Our data are restricted to the prevalence of rotavirus genotypes in the Ahvaz city of Iran. Thus, the prevalence of the rotaviruses genotype including G12 genotype needs to be studied in other parts of Iran. Moreover, the overall prevalence of the G12 rotavirus infection requires to be determined since this study was limited only to hospitalized patients with severe diarrhea. It is now important to compare the antigenic cross-reactivity of the new G12 strains with other common global strains containing vaccine strains. Based on sequence analysis of the *VP7* and *VP4* genotypes described in our study and other reports, distribution of rotavirus genotypes are different in industrialized and developing countries. However, the available data are not sufficient to understand the reasons for this difference. At present, due to the lack of any specific treatment, the rotavirus vaccination program is the only preventive measure against rotavirus infection. Due to the high prevalence of the G9P\[8\] and G12P\[8\] genotypes reported in our study and in two studies by Shoja *et al*.\[[@ref35]\] and Farahtaj *et al*.\[[@ref57]\], it seems that the Rotarix and Rotateq vaccines are ineffective against the mentioned rotavirus genotypes\[[@ref35],[@ref56]\]. The outlook that rotavirus infection in children may soon be prevented by vaccines has placed a new preference on understanding the diversity of rotavirus strains. The study also emphasizes the coverage of G12 primers for all future rotavirus surveillance.

In conclusion, this study revealed the first detection of the G12 strains in the southwest region of Iran. The most common rotavirus genotype found among the patients was the G9P\[8\]. All the rotavirus infections occurred in children aged 2-60 months, with peak cases among those of 6 and 8 months of age. These data suggest that G-P genotype combinations vary with regard to geographical locations. This study strongly emphasizes the need for retaining surveillance on emerging rotavirus strains in Iran, and comprehensive investigations are required to determine the prevalence of rotavirus genotypes in other regions of Iran to develop region-specific vaccines.
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